UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...
UiPath (NYSE:PATH) executives used the company’s latest earnings call question-and-answer session to emphasize what they ...
Zacks Investment Research on MSN
Why UiPath (PATH) is a top momentum stock for the long term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Community driven content discussing all aspects of software development from DevOps to design patterns. The primary concern when it comes to running unattended robots is how to start them. This is the ...
UiPath faces significant challenges, and its stock price reflects them. Leadership changes and solid financial metrics could pave the way to a recovery. The stock price is down 54% from recent highs, ...
UiPath Inc. raised its full-year revenue outlook after cruising past Wall Street’s expectations and swinging to a profit in its latest quarterly results, powered by momentum in its artificial ...
UiPath Inc. is rated a strong buy, with a price target near $18, following a 30% sell-off driven by AI-related sector fears. PATH's robust AI-driven automation platform, strong earnings beats, and 16% ...
Chris Ashley, Director of BD & Strategy at UiPath, doesn't mince words about where most organizations actually stand on data ...
UiPath, Inc. (NYSE: PATH), a global leader in agentic automation, today announced financial results for its fourth quarter ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results